13F-HR filed by Logos Global Management LP
Logos Global Management LP filed this 13F-HR for the quarter ended 2020-03-31, filed 2020-05-15, with 41 holding rows worth $262,899,000.
- Accession
- 0001172661-20-001310
- Filer
- CIK 1792126
- Filed
- 2020-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2020
A holdings report, 41 entries on the cover page, a total value of $262,899,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $262,899,000 with VALUE read as thousands by filing date, 13F file number 028-20025. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AbbVie,Inc. | 00287Y109 | COM | 265,600 | $20,236,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 187,350 | $18,327,000 | thousands by filing date | |
| MYOKARDIA INC | 62857M105 | COM | 300,000 | $14,064,000 | thousands by filing date | |
| MODERNA INC | 60770K107 | COM | 460,000 | $13,777,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 120,000 | $13,513,000 | thousands by filing date | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 82,292 | $11,878,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 194,500 | $10,841,000 | thousands by filing date | |
| ZYMEWORKS INC | 98985W102 | COM | 304,417 | $10,798,000 | thousands by filing date | |
| IGM BIOSCIENCES INC | 449585108 | COM | 173,865 | $9,763,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 185,933 | $9,499,000 | thousands by filing date | |
| PASSAGE BIO INC | 702712100 | COM | 603,338 | $8,960,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 33,237 | $7,909,000 | thousands by filing date | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 775,377 | $7,738,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 247,248 | $7,401,000 | thousands by filing date | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 532,520 | $6,358,000 | thousands by filing date | |
| 89BIO INC | 282559103 | COM | 247,000 | $6,237,000 | thousands by filing date | |
| MOLECULAR TEMPLATES INC | 608550109 | COM | 438,831 | $5,832,000 | thousands by filing date | |
| VERASTEM INC | 92337C104 | COM | 2,325,582 | $5,526,000 | thousands by filing date | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 69,658 | $5,015,000 | thousands by filing date | |
| BRISTOL-MYERS SQUIBB CO | 110122157 | RIGHT 99/99/9999 | 1,275,500 | $4,847,000 | thousands by filing date | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 72,831 | $4,539,000 | thousands by filing date | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 105,512 | $4,475,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 75,000 | $4,386,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 39,644 | $4,315,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 193,144 | $4,290,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 446,882 | $4,129,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 995,600 | $4,022,000 | thousands by filing date | |
| LIFESCI ACQUISITION CORP | 53228P208 | UNIT 03/31/2025 | 400,000 | $3,999,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 152,144 | $3,763,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 276,635 | $3,729,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 46,399 | $3,567,000 | thousands by filing date | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 123,465 | $2,772,000 | thousands by filing date | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 1,111,867 | $2,680,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 33,300 | $2,560,000 | thousands by filing date | call |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 249,844 | $2,458,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 193,129 | $2,277,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 69,591 | $1,999,000 | thousands by filing date | |
| MINERVA NEUROSCIENCES INC COM NEW | 603380106 | Stock | 309,745 | $1,865,000 | thousands by filing date | |
| SAVARA INC | 805111101 | COM | 613,999 | $1,172,000 | thousands by filing date | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 53,034 | $1,162,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 15,809 | $221,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-20-001310 | this filing | 2020-05-15 | acceptance time not in the bulk data set |